推荐产品
等級
pharmaceutical primary standard
API 家族
proline
製造商/商標名
USP
mp
228 °C (dec.) (lit.)
應用
pharmaceutical (small molecule)
格式
neat
SMILES 字串
OC(=O)[C@@H]1CCCN1
InChI
1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1
InChI 密鑰
ONIBWKKTOPOVIA-BYPYZUCNSA-N
正在寻找类似产品? 访问 产品对比指南
一般說明
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
應用
L-Proline USP reference standard suitable for use in specified USP compendial quality tests and assays.
Also used to prepare standard and system suitability solution during the impurity analysis by using thin layer chromatography according to the given below monographs of United States Pharmacopeia (USP):
Also used to prepare standard and system suitability solution during the impurity analysis by using thin layer chromatography according to the given below monographs of United States Pharmacopeia (USP):
- Proline
- Histidine
- Threonine
分析報告
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他說明
Sales restrictions may apply.
儲存類別代碼
13 - Non Combustible Solids
水污染物質分類(WGK)
WGK 1
閃點(°F)
Not applicable
閃點(°C)
Not applicable
其他客户在看
Threonine
United States Pharmacopeia, 4362-4362 (2023)
Proline
United States Pharmacopeia, 3711-3711 (2023)
Histidine
United States Pharmacopeia, 49(3), 2206-2206 (2023)
Applied and environmental microbiology, 81(1), 119-123 (2014-10-19)
Clostridium difficile is an important enteric pathogen of humans and the cause of diarrhea and enteritis in neonatal pigs. Outside Australia, prevalence in piglets can be up to 73%, with a single PCR ribotype (RT), 078, predominating. We investigated the
AIDS patient care and STDs, 28(5), 221-227 (2014-05-07)
The aim of this study was to assess the therapeutic potential of telaprevir (TPV)/boceprevir (BOC)-based triple-therapy in a complete cohort of HIV/chronic hepatitis C co-infected patients (HIV/HCV). Moreover, a case series of four HIV/HCV genotype (HCV-GT)1 patients with rapid virologic
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门